000 01374 a2200385 4500
005 20250513210022.0
264 0 _c20000606
008 200006s 0 0 eng d
022 _a0906-6705
024 7 _a10.1034/j.1600-0625.2000.009002097.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLehmann, B
245 0 0 _aConversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents.
_h[electronic resource]
260 _bExperimental dermatology
_cApr 2000
300 _a97-103 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCells, Cultured
650 0 4 _aCholecalciferol
_xmetabolism
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aHydroxylation
_xdrug effects
650 0 4 _aKeratinocytes
_xdrug effects
650 0 4 _aKetoconazole
_xpharmacology
650 0 4 _aKinetics
650 0 4 _aNADH, NADPH Oxidoreductases
_xantagonists & inhibitors
650 0 4 _aNADPH-Ferrihemoprotein Reductase
650 0 4 _aSerum Albumin, Bovine
_xpharmacology
650 0 4 _aTime Factors
650 0 4 _aVitamin D
_xanalogs & derivatives
700 1 _aRudolph, T
700 1 _aPietzsch, J
700 1 _aMeurer, M
773 0 _tExperimental dermatology
_gvol. 9
_gno. 2
_gp. 97-103
856 4 0 _uhttps://doi.org/10.1034/j.1600-0625.2000.009002097.x
_zAvailable from publisher's website
999 _c10725484
_d10725484